breast cancer
Conditions
Interventions
Operation. Biopsy: We incise skin under local anesthesia, and perform a tumor biopsy by needle.
Sponsors
Department of Clinical Oncology and Chemotherapy, Nagoya University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: a. Histologically proven breast cancer patients b. Patients to perform surgery or biopsy for diagnosis, treatment, or research purposes, in S-1, capecitabine, bevacizumab, trastuzumab, paclitaxel, nab-paclitaxel, or tamoxifen have been administered or scheduled to administer as the standard treatment, c. Performance status (ECOG) 0, 1, 2 d. 20 years of age and older e. Patients with tumor tissue which is thought to be located in safely collected sites f. Written informed consent.
Exclusion criteria
Exclusion criteria: a. Patients with active infection b. Patients with other serious disease c. Patients with coagulation abnormalities or patients who are not possible to rest anticoagulants d. Patients with history of severe drug allergy e. Pregnant or nursing females f. Patients whose participation in the study is judged to be inappropriate by the attending doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| We confirm the correlation between the distribution and effectiveness of anti-cancer agents in breast cancer. | — |
Countries
Japan
Contacts
Public ContactTomoya Shimokata
Nagoya University Graduate School of Medicine Clinical Oncology and Chemotherapy
Outcome results
None listed